Company / Financials
CONMED Corporation Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.4B
FY2025 · +5.2% YoY
Net Income
$47.1M
FY2025 · -64.5% YoY
Profit Margin
3.4%
FY2025 · net income / revenue
ROE
4.5%
FY2025 · return on equity
Total Assets
$2.3B
FY2025
Total Debt
-
FY2025
Equity
$1.0B
FY2025
ROA
2.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.4B+5.2% YoYNet Income HistoryProfit after all expenses and taxes$47.1M-64.5% YoYGross Profit HistoryRevenue minus cost of goods sold$750.5M+2.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$624.2M+8.8% YoYOperating Income HistoryProfit from core business operations before interest and taxes$102.6M-48.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$592.0M+23.8% YoYR&D Expense HistoryResearch and development spending$55.9M+2.7% YoYInterest Expense HistoryCost of borrowing and debt obligations$31.1M-16.7% YoYIncome Tax HistoryTotal income tax expense$24.1M-21.4% YoYEPS (Basic) HistoryBasic earnings per share$2.10+178.4% YoY